» Articles » PMID: 24836468

International Variation in Lung Cancer Mortality Rates and Trends Among Women

Overview
Date 2014 May 20
PMID 24836468
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is no recent comprehensive global analysis of lung cancer mortality in women. We describe contemporary mortality rates and trends among women globally.

Methods: We used the World Health Organization's Cancer Mortality Database covering 65 populations on six continents to calculate age-standardized (1960 Segi world standard) lung cancer death rates during 2006 to 2010 and annual percent change in rates for available years from 1985 to 2011 and for the most recent five data years by population and age group (30-49 and 50-74 years).

Results: Lung cancer mortality rates (per 100,000) among young women (30-49 years) during 2006 to 2010 ranged from 0.7 in Costa Rica to 14.8 in Hungary. Rates among young women were stable or declining in 47 of 52 populations examined. Rates among women 50 to 74 years ranged from 8.8 in Georgia and Egypt to 120.0 in Scotland. In both age groups, rates were highest in parts of Europe (Scotland, Hungary, Denmark) and North America and lowest in Africa, Asia, and Latin America. Rates in older women were increasing for more than half (36/64) of populations examined, including most countries in Southern, Eastern, and Western Europe and South America.

Conclusions: Although widespread reductions in lung cancer in young women provide evidence of tobacco control success, rates continue to increase among older women in many countries.

Impact: More concentrated efforts to initiate or expand tobacco control programs in these countries globally will be required to attenuate the future lung cancer burden. Cancer Epidemiol Biomarkers Prev; 23(6); 1025-36. ©2014 AACR.

Citing Articles

Association of hemoglobin, albumin, lymphocyte, and platelet score with risk of all-cause and cause-specific mortality among cancer survivors: NHANES 1999-2018.

Fu J, Yue X, Zou Y, Zhang J, Wang X, Zhang D Front Oncol. 2024; 14:1402217.

PMID: 39359427 PMC: 11445657. DOI: 10.3389/fonc.2024.1402217.


Cancer prevalence, incidence, and mortality rates in Afghanistan in 2020: A review study.

Shayan N, Rahimi A, Ozcebe H Cancer Rep (Hoboken). 2023; 6(9):e1873.

PMID: 37574721 PMC: 10480416. DOI: 10.1002/cnr2.1873.


Epidemiology of Lung Cancer in Kazakhstan: Trends and Geographic Distribution.

Yessenbayev D, Khamidullina Z, Tarzhanova D, Orazova G, Zhakupova T, Kassenova D Asian Pac J Cancer Prev. 2023; 24(5):1521-1532.

PMID: 37247271 PMC: 10495898. DOI: 10.31557/APJCP.2023.24.5.1521.


Epidemiological and demographic drivers of lung cancer mortality from 1990 to 2019: results from the global burden of disease study 2019.

Fan Y, Jiang Y, Gong L, Wang Y, Su Z, Li X Front Public Health. 2023; 11:1054200.

PMID: 37213644 PMC: 10196253. DOI: 10.3389/fpubh.2023.1054200.


Trends in hospitalization and in-hospital mortality rates among patients with lung cancer in Spain between 2010 and 2020.

Galindo-Utrero A, San-Roman-Montero J, Gil-Prieto R, Gil-de-Miguel A BMC Cancer. 2022; 22(1):1199.

PMID: 36411427 PMC: 9680125. DOI: 10.1186/s12885-022-10205-2.